Literature DB >> 25146612

Association of poly(ADP-ribose) polymerase activity in circulating mononuclear cells with myocardial dysfunction in patients with septic shock.

Li Li1, Bangchuan Hu2, Shijin Gong1, Yihua Yu1, Haiwen Dai1, Jing Yan3.   

Abstract

BACKGROUND: Severe sepsis and septic shock are the leading causes of morbidity and mortality in hospitalized patients. This study aimed to investigate the association of poly (ADP-ribose) polymerase-1 (PARP-1) activity in circulating mononuclear cells with myocardial dysfunction in patients with septic shock.
METHODS: A total of 64 patients with septic shock were divided into the survival group (n = 41) and the nonsurvival group (n = 23) according to mortality at 28 days after enrollments. PARP-1 activity in circulating mononuclear cells, brain natriuretic peptide, Acute Physiology and Chronic Health Evaluation II score, the cardiac index (CI), the cardiac function index (CFI), global ejection fraction (GEF), and the left ventricular contractility index (dp/dt max) were measured after admission to the intensive care unit.
RESULTS: PARP-1 activity in circulating mononuclear cells of nonsurvival patients with septic shock was significantly higher than that in survival patients. PARP-1 activity in circulating mononuclear cells was strongly, negatively correlated with the CI, the CFI, GEF, and dp/dt max. Multiple Logistic regression analysis showed that PARP-1 activity in circulating mononuclear cells was an independent risk factor of myocardial dysfunction. The optimal cutoff point of PARP-1 activity for predicting 28-day mortality was 942 nmol/L with a sensibility of 78.2% and specificity of 65.1%.
CONCLUSION: PARP-1 activity in circulating mononuclear cells is significantly associated with myocardial dysfunction and may have prognostic value in patients with septic shock.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25146612

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  3 in total

1.  Effects of the PARP Inhibitor Olaparib on the Response of Human Peripheral Blood Leukocytes to Bacterial Challenge or Oxidative Stress.

Authors:  Sidneia Sousa Santos; Milena Karina Coló Brunialti; Larissa de Oliveira Cavalcanti Peres Rodrigues; Ana Maria Alvim Liberatore; Ivan Hong Jun Koh; Vanessa Martins; Francisco Garcia Soriano; Csaba Szabo; Reinaldo Salomão
Journal:  Biomolecules       Date:  2022-06-04

Review 2.  PARP Inhibitors: An Innovative Approach to the Treatment of Inflammation and Metabolic Disorders in Sepsis.

Authors:  Weronika Wasyluk; Agnieszka Zwolak
Journal:  J Inflamm Res       Date:  2021-05-06

3.  Oxidative Stress-Related Parthanatos of Circulating Mononuclear Leukocytes in Heart Failure.

Authors:  Tamás Bárány; Andrea Simon; Gergő Szabó; Rita Benkő; Zsuzsanna Mezei; Levente Molnár; Dávid Becker; Béla Merkely; Endre Zima; Eszter M Horváth
Journal:  Oxid Med Cell Longev       Date:  2017-11-09       Impact factor: 6.543

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.